Navigation Links
Peregrine Pharmaceuticals Announces Implementation of 1:5 Reverse Stock Split to Take Effect October 19, 2009
Date:10/16/2009

TUSTIN, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that a previously approved reverse split of its common stock will take effect at the start of NASDAQ trading on Monday, October 19, 2009 on a 1-for-5 split-adjusted basis. Peregrine's shares will continue to trade on the NASDAQ Capital Market under the symbol "PPHM," with the letter "D" added to the end of the trading symbol for a period of 20 trading days to indicate the reverse stock split has occurred. The Company's symbol will revert back to its original symbol "PPHM" on November 16, 2009. A new CUSIP number will be assigned to Peregrine's common stock when the split becomes effective.

"We believe that our continued listing on the NASDAQ Stock Market is essential to our future success, and we expect that this reverse stock split will enable us to regain compliance with the minimum bid price rule, the only deficiency affecting our continued NASDAQ listing," noted Paul Lytle, CFO of Peregrine. "The 1:5 exchange ratio that was approved by the Board of Directors is the result of both our extensive evaluations of the capital structure of peer companies in Phase II and Phase III clinical trials and the expert advice of a number of highly experienced financial advisors. Based on previous meetings with institutional investors, we also expect the new capital structure will allow us to attract a broader range of investors to our company."

The 1-for-5 reverse stock split will automatically convert five current shares of Peregrine's common stock into one new share of common stock. The reverse split, which was approved by Peregrine shareholders in October 2008, will reduce the number of shares of outstanding common stock from approximately 237 million as of the filing of the Company's most recent Quarterly Report on Fo
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2010
2. Peregrine Pharmaceuticals Adds Noted Oncologist Dr. Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs
3. NIAID Awards New Grant to Expand Studies of Peregrines Anti-PS Antibodies to Treat Viral Hemorrhagic Fevers
4. Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
5. Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
6. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform
7. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
8. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
9. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
10. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
11. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... in Australia examined patient and tumor characteristics for ... tumor cell growth) in an effort to increase ... , Author: Sarah Shen, M.B.B.S., ... colleagues. , Background: The tumor characteristic known ... been connected with prognosis and survival in melanoma ...
(Date:8/20/2014)... researchers have discovered that the immune system is defective ... major reason why sufferers have ongoing issues with pain. , ... world could also help to explain why some painkillers ... syndrome (IBS) affects up to 10% of the community. ... involve unexplained gut pain, which often has the greatest impact ...
(Date:8/20/2014)... vaccines is now, Free content, The time to ... commentary being published early online today in ... Yale School of Public Health write that the relentless ... outbreak represent a public health crisis that shows no ... have been developed in the last decade, yet the ...
(Date:8/20/2014)... -- Pigs, hearts transplanted into baboons survived for more ... previously achieved, researchers report. The work is part ... to shorten transplant waiting lists. In this study, ... abdomens. The genetic engineering and new methods of suppressing ... hearts to survive for more than a year. ...
(Date:8/20/2014)... (HealthDay News) -- Loss of brain cells that act ... seniors have trouble falling and staying asleep, a new ... be especially severe and often results in nighttime confusion ... analyzed data from the Rush Memory and Aging Project, ... 65 and are being followed until death, at which ...
Breaking Medicine News(10 mins):Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:Pain treatments less effective for those with irritable bowel 2Health News:News from Annals of Internal Medicine 2Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2
... Goodwin HealthDay Reporter , WEDNESDAY, March 14 ... with acute myeloid leukemia, researchers were able to more ... going into remission, and which ones would respond well ... Doctors from Memorial Sloan-Kettering Cancer Center in New York ...
... HealthDay Reporter , WEDNESDAY, March 14 (HealthDay News) -- People ... a genetic predisposition to be overweight, compared to those who ... The findings don,t prove that the exercise is the ... something else could explain why those who walked were thinner, ...
... of UCLA suggested that meditating for years thickens the ... between brain cells. Now a further report by UCLA ... Luders, an assistant professor at the UCLA Laboratory of ... have larger amounts of gyrification ("folding" of the cortex, ...
... acts of racial discrimination is enough to depress anyone, ... to stress with stoicism and emotional control experience more ... of North Carolina at Chapel Hill. The study, ... Moderators of the Racial DiscriminationDepressive Symptoms Association Among African-American ...
... molecules in a drop of a patient,s blood to detect ... drug ferry that doesn,t release its toxic contents until it ... be game changers in how we diagnose, monitor and treat ... the California Institute of Technology, and a member of the ...
... infected with hepatitis C virus (HCV) would likely ... published in Clinical Infectious Diseases and ... mortality and morbidity, however, will require a coordinated ... also linking those infected with the treatment they ...
Cached Medicine News:Health News:Detailed Gene Scan Might Help Guide Leukemia Treatment 2Health News:Detailed Gene Scan Might Help Guide Leukemia Treatment 3Health News:Detailed Gene Scan Might Help Guide Leukemia Treatment 4Health News:Brisk Daily Walk Could Counter 'Obesity Genes' 2Health News:Evidence builds that meditation strengthens the brain, UCLA researchers say 2Health News:Hiding emotions may exacerbate depression among black men who confront racial discrimination 2Health News:Fighting cancer with nanotechnology 2Health News:Broader screening for hepatitis C would be cost effective, study suggests 2
(Date:8/20/2014)... The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 7,481 boxes of ...
(Date:8/20/2014)... Reportlinker.com announces that a new market ... The Impact of Healthcare Reform (PPACA) On ... http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html The "Patient Protection and ... that affects virtually every aspect of health care, ... take effect now. IVD manufacturers who have different ...
(Date:8/20/2014)... 2014 Research and Markets ... Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) ... to their offering. A new ... geography) - Size, Share, Global Trends, Company Profiles, ... Forecast, 2013 - 2020", suggests that the global ...
Breaking Medicine Technology:Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2
... 24, 2012   Sanovas , a leading developer ... cancer and chronic diseases, announced today that it ... manufacturing site in Sausalito, Calif. The facility will ... of filing for U.S. Food and Drug Administration ...
... Medical Inc. (OTCBB:ONCS), which is developing its ... therapies to treat solid tumor cancers, today announced ... OncoSec, will be presenting at the World Cancer ... (Logo:  http://photos.prnewswire.com/prnh/20110314/MM64943LOGO ) ...
Cached Medicine Technology:Sanovas Expands Headquarters and Opens Manufacturing Site 2OncoSec to Present at World Cancer Immunotherapy Conference 2OncoSec to Present at World Cancer Immunotherapy Conference 3
... linear stapler with LACTOMER™ 9-1 absorbable ... POLY CS™-57 disposable surgical stapler has ... temporary opening, such as a hysterotomy ... when transecting muscle tissue, to maintain ...
... Units With Titanium Staples for ... (Single Use Reloadable Stapler with ... Suture™ PREMIUM MULTIFIRE TA™ stapler ... pediatric and thoracic surgical procedures ...
... Use Loading Units for use ... Use Reloadable Staplers with Titanium ... TA™ Reloadable staplers has application ... thoracic surgical procedures for resection ...
... linear stapler for resection, transection and anastomosis ... MULTIFIRE GIA™ 60 and 80 single use ... 80 single use loading units and the ... use surgical stapler with MULTIFIRE SGIA™ 60 ...
Medicine Products: